Blood clots can happen to anyone.

Deep vein thrombosis (DVT): blood clot located in a deep vein, usually in a leg or arm.

Pulmonary embolism (PE): blood clot that has traveled from a deep vein to a lung. DVT and PE are also known as VTE (venous thromboembolism).

The Problem

  • VTE affects as many as 900,000 Americans each year.

  • 3 in 10 people who have a blood clot will have another episode within 10 years.

  • As many as 100,000 people die of blood clots each year.

  • PE is a leading cause of death in a woman during pregnancy or just after having a baby.

  • Sudden death – 1 of 4 people who have a PE die without warning.

  • Blood clots are a leading cause of death in people with cancer after the cancer itself.

  • Misdiagnosis of swelling and pain by primary care physician

  • Misunderstanding of clot formation, clot movement, & diagnosis limitations

Impacts of blood clots in US

Source: CDC GOV

  • Factors - Elderly (age>60), pregnancy, lack of movement (>4hr) (longer flight, bed-rest, heavy traffic, Covid-19 lockdown/ICU!), disease (diabetes, cancer, obesity & Covid-19), surgeries, & accidents

Prevention

  • Early diagnosis is critical to prevent death. PE (2-4%) but preventable if diagnosed early / correctly

Technology

We use advanced modeling and simulation technologies of vascular pulmonary networked system to provide high-fidelity noninvasive early diagnosis and predictive assessment of Deep Vein Thrombosis (DVT) & Pulmonary Embolism (PE). Leveraging leading-edge applied mathematics and web driven cloud computing framework, we make rapid prototyping of the DVT/PE simulations technologies and deploy them at-scale, and make them accessible to doctors and healthcare professionals and other stakeholders through intuitive user-friendly interfaces. We strive to deliver our products completely via the web and apps at affordable prices that can be used by anyone & everyone without domain knowledge of the physical and computing processes.